Manulife (Manufacturers Life Insurance)
AKBA icon

Manulife (Manufacturers Life Insurance)’s Akebia Therapeutics AKBA Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$95.9K Sell
68,973
-51,425
-43% -$70.7K ﹤0.01% 2633
2025
Q4 		$194K Sell
120,398
-5,821
-5% -$12.2K ﹤0.01% 2541
2025
Q3 		$345K Buy
126,219
+36,542
+41% +$122K ﹤0.01% 2335
2025
Q2 		$326K Buy
89,677
+15,867
+21% +$43.6K ﹤0.01% 2359
2025
Q1 		$142K Sell
73,810
-1,807
-2% -$3.69K ﹤0.01% 2601
2024
Q4 		$144K Sell
75,617
-2,827
-4% -$4.91K ﹤0.01% 2731
2024
Q3 		$104K Buy
+78,444
New +$105K ﹤0.01% 2862
2022
Q2 		– Sell
-78,736
Closed -$56.5K – 3001
2022
Q1 		$56.5K Sell
78,736
-20,212
-20% -$43.2K ﹤0.01% 3034
2021
Q4 		$224 Sell
98,948
-3,942
-4% -$10.7K ﹤0.01% 2830
2021
Q3 		$296K Buy
102,890
+7,940
+8% +$22.7K ﹤0.01% 2676
2021
Q2 		$360K Buy
94,950
+6,285
+7% +$21.2K ﹤0.01% 2675
2021
Q1 		$300K Sell
88,665
-1,786
-2% -$6.43K ﹤0.01% 2626
2020
Q4 		$253K Buy
90,451
+9,106
+11% +$26.6K ﹤0.01% 2620
2020
Q3 		$204K Buy
81,345
+3,869
+5% +$34K ﹤0.01% 2553
2020
Q2 		$984K Buy
77,476
+1,614
+2% +$16.7K ﹤0.01% 1625
2020
Q1 		$575K Buy
75,862
+3,933
+5% +$30.6K ﹤0.01% 1761
2019
Q4 		$455K Sell
71,929
-3,002
-4% -$14.3K ﹤0.01% 2105
2019
Q3 		$309K Hold
74,931
– – ﹤0.01% 2302
2019
Q2 		$363K Buy
74,931
+17,262
+30% +$98.2K ﹤0.01% 2245
2019
Q1 		$472K Buy
57,669
+1,991
+4% +$13.7K ﹤0.01% 2118
2018
Q4 		$308K Buy
55,678
+20,654
+59% +$162K ﹤0.01% 2158
2018
Q3 		$309K Sell
35,024
-4,917
-12% -$44K ﹤0.01% 2529
2018
Q2 		$399K Buy
39,941
+5,620
+16% +$56.3K ﹤0.01% 2568
2018
Q1 		$327K Sell
34,321
-404
-1% -$5.65K ﹤0.01% 2648
2017
Q4 		$516K Buy
34,725
+93
+0.3% +$1.54K ﹤0.01% 2300
2017
Q3 		$681K Buy
34,632
+4,904
+16% +$75.4K ﹤0.01% 2054
2017
Q2 		$427K Sell
29,728
-651
-2% -$8.25K ﹤0.01% 2414
2017
Q1 		$279K Buy
30,379
+3,344
+12% +$32.6K ﹤0.01% 2600
2016
Q4 		$281K Buy
27,035
+629
+2% +$5.42K ﹤0.01% 2527
2016
Q3 		$239K Buy
26,406
+117
+0.4% +$995 ﹤0.01% 2635
2016
Q2 		$196K Buy
26,289
+7,000
+36% +$61.1K ﹤0.01% 2723
2016
Q1 		$172K Buy
19,289
+1,790
+10% +$14.5K ﹤0.01% 2703
2015
Q4 		$226 Hold
17,499
– – ﹤0.01% 2563
2015
Q3 		$170 Buy
17,499
+108
+0.6% +$991 ﹤0.01% 2779
2015
Q2 		$179 Buy
17,391
+15,432
+788% +$132K ﹤0.01% 2946
2015
Q1 		$22 Buy
1,959
+365
+23% +$3.89K ﹤0.01% 3452
2014
Q4 		$18 Sell
1,594
-4,022
-72% -$57.7K ﹤0.01% 3379
2014
Q3 		$125 Buy
5,616
+441
+9% +$10.1K ﹤0.01% 2969
2014
Q2 		$144K Buy
+5,175
New +$125K ﹤0.01% 2962

Other funds holding AKBA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Manulife (Manufacturers Life Insurance)'s AKBA Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Akebia Therapeutics (AKBA) stake by 43% in Q1 2026, selling an estimated $70.7K and leaving 68,973 shares worth $95.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2633.

Manulife (Manufacturers Life Insurance) first reported a position in AKBA in Q2 2014 and has held it in 39 quarters since. The position peaked at $984K in Q2 2020. 171 funds tracked by Wall St. Rank hold AKBA as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 68,973 shares of Akebia Therapeutics worth $95.9K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 51,425 Akebia Therapeutics shares in Q1 2026, an estimated $70.7K.
  • Akebia Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2633 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Akebia Therapeutics in Q2 2014 and has held it in 39 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Akebia Therapeutics position peaked at $984K in Q2 2020.
  • 171 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.